Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:02 pm Unchanged | 13G | Co-Diagnostics Inc. CODX | VANGUARD GROUP INC | 1,781,283 5.820% | 0 (Unchanged) | View |
| 2023-02-09 11:15 am Sale | 13G | Co-Diagnostics Inc. CODX | VANGUARD GROUP INC | 1,781,283 5.760% | -13,774 (-0.77%) | View |
| 2022-02-09 3:43 pm Purchase | 13G | Co-Diagnostics Inc. CODX | VANGUARD GROUP INC | 1,795,057 5.300% | 181,173 (+11.23%) | View |
| 2021-07-12 08:29 am Sale | 13G | Co-Diagnostics Inc. CODX | BlackRock Inc. BLK | 517,938 1.800% | -1,403,732 (-73.05%) | View |
| 2021-02-10 10:46 am Purchase | 13G | Co-Diagnostics Inc. CODX | VANGUARD GROUP INC | 1,613,884 5.710% | 1,613,884 (New Position) | View |
| 2021-02-02 3:13 pm Purchase | 13G | Co-Diagnostics Inc. CODX | BlackRock Inc. BLK | 1,921,670 6.800% | 1,921,670 (New Position) | View |
| 2021-01-04 11:58 am Sale | 13G | Co-Diagnostics Inc. CODX | SABBY MANAGEMENT LLC | 0 0.000% | -1,379,311 (Position Closed) | View |
| 2020-02-10 3:15 pm Sale | 13G | Co-Diagnostics Inc. CODX | CVI Investments Inc. | 0 0.000% | -1,308,572 (Position Closed) | View |
| 2020-01-28 1:20 pm Purchase | 13G | Co-Diagnostics Inc. CODX | SABBY MANAGEMENT LLC | 1,379,311 11.000% | 1,379,311 (New Position) | View |
| 2020-01-03 11:40 am Sale | 13G | Co-Diagnostics Inc. CODX | SABBY MANAGEMENT LLC | 0 0.000% | -1,308,572 (Position Closed) | View |